These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1533423)

  • 1. Exploration of N-phosphonoalkyl-, N-phosphonoalkenyl-, and N-(phosphonoalkyl)phenyl-spaced alpha-amino acids as competitive N-methyl-D-aspartic acid antagonists.
    Bigge CF; Johnson G; Ortwine DF; Drummond JT; Retz DM; Brahce LJ; Coughenour LL; Marcoux FW; Probert AW
    J Med Chem; 1992 Apr; 35(8):1371-84. PubMed ID: 1533423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of N-methyl-D-aspartate agonist and competitive antagonist pharmacophore models. Design and synthesis of phosphonoalkyl-substituted tetrahydroisoquinolines as novel antagonists.
    Ortwine DF; Malone TC; Bigge CF; Drummond JT; Humblet C; Johnson G; Pinter GW
    J Med Chem; 1992 Apr; 35(8):1345-70. PubMed ID: 1533422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of phenyl-spaced 2-amino-(5-9)-phosphonoalkanoic acids as competitive N-methyl-D-aspartic acid antagonists.
    Bigge CF; Drummond JT; Johnson G; Malone T; Probert AW; Marcoux FW; Coughenour LL; Brahce LJ
    J Med Chem; 1989 Jul; 32(7):1580-90. PubMed ID: 2544728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent quinoxaline-spaced phosphono alpha-amino acids of the AP-6 type as competitive NMDA antagonists: synthesis and biological evaluation.
    Baudy RB; Greenblatt LP; Jirkovsky IL; Conklin M; Russo RJ; Bramlett DR; Emrey TA; Simmonds JT; Kowal DM; Stein RP
    J Med Chem; 1993 Feb; 36(3):331-42. PubMed ID: 8093907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity analysis of binding kinetics for NMDA receptor competitive antagonists: the influence of conformational restriction.
    Benveniste M; Mayer ML
    Br J Pharmacol; 1991 Sep; 104(1):207-21. PubMed ID: 1686203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and activity of a potent N-methyl-D-aspartic acid agonist, trans-1-aminocyclobutane-1,3-dicarboxylic acid, and related phosphonic and carboxylic acids.
    Allan RD; Hanrahan JR; Hambley TW; Johnston GA; Mewett KN; Mitrovic AD
    J Med Chem; 1990 Oct; 33(10):2905-15. PubMed ID: 2145435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pharmacological evaluation of 4a-phenanthrenamine derivatives acting at the phencyclidine binding site of the N-methyl-D-aspartate receptor complex.
    Bigge CF; Malone TC; Hays SJ; Johnson G; Novak PM; Lescosky LJ; Retz DM; Ortwine DF; Probert AW; Coughenour LL
    J Med Chem; 1993 Jul; 36(14):1977-95. PubMed ID: 8336337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain.
    Foster AC; Wong EH
    Br J Pharmacol; 1987 Jun; 91(2):403-9. PubMed ID: 2886170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New and versatile approaches to the synthesis of CPP-related competitive NMDA antagonists. Preliminary structure-activity relationships and pharmacological evaluation.
    Hays SJ; Bigge CF; Novak PM; Drummond JT; Bobovski TP; Rice MJ; Johnson G; Brahce LJ; Coughenour LL
    J Med Chem; 1990 Oct; 33(10):2916-24. PubMed ID: 2145436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of LY233053: a structurally novel tetrazole-substituted competitive N-methyl-D-aspartic acid antagonist with a short duration of action.
    Schoepp DD; Ornstein PL; Leander JD; Lodge D; Salhoff CR; Zeman S; Zimmerman DM
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1301-8. PubMed ID: 2148188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the binding of [3H]-CGS 19755: a novel N-methyl-D-aspartate antagonist with nanomolar affinity in rat brain.
    Murphy DE; Hutchison AJ; Hurt SD; Williams M; Sills MA
    Br J Pharmacol; 1988 Nov; 95(3):932-8. PubMed ID: 2850065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-(Tetrazolylalkyl)piperidine-2-carboxylic acids. Potent and selective N-methyl-D-aspartic acid receptor antagonists with a short duration of action.
    Ornstein PL; Schoepp DD; Arnold MB; Leander JD; Lodge D; Paschal JW; Elzey T
    J Med Chem; 1991 Jan; 34(1):90-7. PubMed ID: 1825117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
    Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW
    Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacological specificity of N-methyl-D-aspartate receptors in rat cerebral cortex: correspondence between radioligand binding and electrophysiological measurements.
    Grimwood S; Foster AC; Kemp JA
    Br J Pharmacol; 1991 Jun; 103(2):1385-92. PubMed ID: 1832067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-(Phosphonoalkyl)- and 4-(phosphonoalkenyl)-2-piperidinecarboxylic acids: synthesis, activity at N-methyl-D-aspartic acid receptors, and anticonvulsant activity.
    Hutchison AJ; Williams M; Angst C; de Jesus R; Blanchard L; Jackson RH; Wilusz EJ; Murphy DE; Bernard PS; Schneider J
    J Med Chem; 1989 Sep; 32(9):2171-8. PubMed ID: 2549246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of organophosphate interactions at N-methyl-D-aspartate receptors in brain synaptic membranes.
    Johnson PS; Michaelis EK
    Mol Pharmacol; 1992 Apr; 41(4):750-6. PubMed ID: 1533269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel class of amino acid antagonists at non-N-methyl-D-aspartic acid excitatory amino acid receptors. Synthesis, in vitro and in vivo pharmacology, and neuroprotection.
    Krogsgaard-Larsen P; Ferkany JW; Nielsen EO; Madsen U; Ebert B; Johansen JS; Diemer NH; Bruhn T; Beattie DT; Curtis DR
    J Med Chem; 1991 Jan; 34(1):123-30. PubMed ID: 1825114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacology of a series of 3- and 4-(phosphonoalkyl)pyridine- and -piperidine-2-carboxylic acids. Potent N-methyl-D-aspartate receptor antagonists.
    Ornstein PL; Schaus JM; Chambers JW; Huser DL; Leander JD; Wong DT; Paschal JW; Jones ND; Deeter JB
    J Med Chem; 1989 Apr; 32(4):827-33. PubMed ID: 2539478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.
    Carter C; Benavides J; Legendre P; Vincent JD; Noel F; Thuret F; Lloyd KG; Arbilla S; Zivkovic B; MacKenzie ET
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.
    Lehmann J; Schneider J; McPherson S; Murphy DE; Bernard P; Tsai C; Bennett DA; Pastor G; Steel DJ; Boehm C
    J Pharmacol Exp Ther; 1987 Mar; 240(3):737-46. PubMed ID: 2882014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.